» Articles » PMID: 24712014

Idiopathic Pulmonary Fibrosis: New Insights on Functional Characteristics at Diagnosis

Overview
Journal Can Respir J
Publisher Wiley
Specialty Pulmonary Medicine
Date 2014 Apr 9
PMID 24712014
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The lung function of patients with idiopathic pulmonary fibrosis (IPF) has not been characterized in detail. objective: To characterize the heterogeneous physiological abnormalities that exist in patients with IPF during their initial clinical evaluation.

Methods: Lung function tests from 93 patients, performed within six months of the initial diagnosis of IPF, were obtained from a referral pulmonary function laboratory at a tertiary care hospital in Canada. A restrictive pattern was defined as total lung capacity (TLC) <95th percentile of predicted value. Patients with obstructive lung disease, lung cancer, emphysema and other restrictive lung diseases were excluded.

Results: On diagnosis, 73% of patients with IPF had a restrictive pattern, with a mean TLC of 72% of predicted. Mean forced vital capacity (FVC) was 71% and 44% of patients had an FVC <95th percentile. Mean diffusing capacity for carbon monoxide (DLCO) was 60% and DLCO⁄alveolar volume (VA) 92% of predicted. Increased severity of restriction - based on TLC - was associated with lower DLCO (74% of predicted in mild restriction and 39% of predicted in severe restriction) and higher forced expiratory volume in 1 s (FEV1)⁄FVC ratio (82% of predicted in mild restriction and 90% of predicted in severe restriction) but not with age (76 years in mild restriction and 69 years in severe restriction). Regardless of severity of restriction, the average DLCO⁄VA (≥86% of predicted) remained within normal limits.

Conclusions: One in four patients with IPF had normal TLC and more than one-half had a normal FVC during initial evaluation. As the severity of the restriction increased, FEV1⁄FVC increased, DLCO decreased but DLCO⁄VA remained normal.

Citing Articles

Imaging of Pulmonary Sarcoidosis-A Review.

Bailey G, Wells A, Desai S J Clin Med. 2024; 13(3).

PMID: 38337517 PMC: 10856519. DOI: 10.3390/jcm13030822.


Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis.

Murgo A, Bignami F, Federico G, Villetti G, Civelli M, Sala A Front Pharmacol. 2023; 14:1303646.

PMID: 38099140 PMC: 10719847. DOI: 10.3389/fphar.2023.1303646.


Precision medicine advances in idiopathic pulmonary fibrosis.

Karampitsakos T, Juan-Guardela B, Tzouvelekis A, Herazo-Maya J EBioMedicine. 2023; 95:104766.

PMID: 37625268 PMC: 10469771. DOI: 10.1016/j.ebiom.2023.104766.


Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks.

Patrucco F, Solidoro P, Gavelli F, Apostolo D, Bellan M Microorganisms. 2023; 11(4).

PMID: 37110318 PMC: 10146995. DOI: 10.3390/microorganisms11040895.


Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19.

van Raaij B, Stoger J, Hinnen C, Penfornis K, de Jong C, Klok F Respir Med Res. 2022; 82:100973.

PMID: 36403358 PMC: 9670737. DOI: 10.1016/j.resmer.2022.100973.


References
1.
Wanger J, Clausen J, Coates A, Pedersen O, Brusasco V, Burgos F . Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26(3):511-22. DOI: 10.1183/09031936.05.00035005. View

2.
GOLDMAN H, BECKLAKE M . Respiratory function tests; normal values at median altitudes and the prediction of normal results. Am Rev Tuberc. 1959; 79(4):457-67. DOI: 10.1164/artpd.1959.79.4.457. View

3.
Mogulkoc N, Brutsche M, Bishop P, Greaves S, Horrocks A, Egan J . Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med. 2001; 164(1):103-8. DOI: 10.1164/ajrccm.164.1.2007077. View

4.
Ley B, Collard H, King Jr T . Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010; 183(4):431-40. DOI: 10.1164/rccm.201006-0894CI. View

5.
Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A . Standardisation of spirometry. Eur Respir J. 2005; 26(2):319-38. DOI: 10.1183/09031936.05.00034805. View